Rakesh Sachdev - 14 Oct 2025 Form 4 Insider Report for REGAL REXNORD CORP (RRX)

Source evidence 5 source fields
Form type
4
Accepted by SEC
16 Oct 2025, 18:14:18 UTC
Previous filing
16 Jul 2025
Next filing
16 Jan 2026
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Molly Johnson, as Power of Attorney

Key filing fact

Rakesh Sachdev filed Form 4 for REGAL REXNORD CORP (RRX) on 16 Oct 2025.

Key facts

  • This page summarizes Rakesh Sachdev's Form 4 filing for REGAL REXNORD CORP (RRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Oct 2025, 18:14.

Change

  • Previous filing in this sequence was filed on 16 Jul 2025.
  • Current net transaction value: +$451.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001259543 Primary reporting owner

SACHDEV RAKESH

Relationship
Director
Address
111 WEST MICHIGAN STREET, MILWAUKEE
Signature
/s/ Molly Johnson, as Power of Attorney
Signature date
16 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RRX transaction

Common Stock

Award

Transaction value
$451
Shares
+3
Change %
+0.01%
Price
$143.14
Shares after
27,335
Date
14 Oct 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents additional restricted stock units credited to the reporting person under the dividend equivalent reinvestment provision of the reporting person's outstanding restricted stock unit awards as a result of a quarterly dividend payment. The additional restricted stock units resulting from the dividend equivalent reinvestment are subject to the same terms and conditions, including vesting, as the outstanding restricted stock unit awards to which they are attributable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .